Home Page Hot Legal Issues Beyaz
Beyaz Birth Control
En Español [BEYAZ]
On September 26, 2011, the FDA issued a warning that the use of birth control medications that contain drospirenone could potentially be linked to an increased risk of blood clots. The announcement came after the FDA completed a review of two studies from 2011 that evaluated the risk of blood clots in women who use medications that contain drospirenone. Furthermore, the FDA has funded a study that evaluates the risk of blood clots in women who use hormonal birth control products. Preliminary results of that study suggest that women who take a birth control pill containing drospirenone has approximately 1.5 times the risk of blood clots of women who use other hormonal contraceptives.
Beyaz Side Effects
On May 31, 2011, the FDA issued an alert that the agency was assessing information about the risks associated with the use of drospirenone in birth control pills. According to the announcement, drospirenone is a type of female hormone called progestin.
"All birth control pills pose a risk of blood clots," the FDA announcement stated. "Several epidemiological studies have reported that the risk of blood clots for women who use birth control pills containing drospirenone is higher than that for women who use birth control pills containing the progestin levonorgestrel. Other studies have not reported an increase in risk."
On December 8, 2011, an FDA advisory panel ruled that birth control drugs containing drosperinone should include a warning about the risk of blood clots. The panel voted 21 to 5 that current warnings concerning the risk of blood clots were not strong enough and recommended that the FDA should strengthen those warnings. The panel voted 15 to 11 to keep drospirenone birth control medications on the market.
Blood clots can be serious, especially if they form in a deep vein (a condition called deep vein thrombosis, or DVT). If blood clots break loose from the vein and move to the lung, they can cause a pulmonary embolism, which can be fatal. According to the FDA, two recently published studies found an increased risk for blood clots in women taking drospirenone-containing pills compared with women taking levonorgestrel-containing pills.
A study published in the British Medical Journal (04/21/11) found that women who are currently using contraceptives that contain drospirenone had approximately three times the risk of developing a non-fatal idiopathic venous thromboembolism as women who used contraceptives that contain levonorgestrel.
Beyaz Blood Clots
"This study adds to the emerging evidence that use of the oral contraceptive containing drospirenone is associated with a higher risk of venous thromboemolism than are preparations containing levonorgestrel," researchers wrote. "Perhaps now is the time for a systematic review on this topic." They went on to note that there is no clear evidence that drospirenone pills have greater benefits than contraceptives that contain levonorgestrel, making drospirenone a less than ideal first line contraceptive.
Meanwhile, a second study also published in the British Medical Journal (04/21/11) found that woman who used birth control that contained drospirenone had approximately double the risk of non-fatal venous thromboembolism as women who used a birth control that contained levonorgestrel.
According to the website, Beyaz is a birth control pill that also provides a daily dose of folate, which is a B vitamin. Beyaz is approved to prevent pregnancy, provide daily folate supplementation and treat premenstrual dysphoric disorder. Beyaz is manufactured by Bayer HealthCare Pharmaceuticals.
Beyaz Legal HelpIf you or a loved one has suffered damages in this case, please click the link below and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation.
Last updated on Feb-17-14
BEYAZ LEGAL ARTICLES AND INTERVIEWS
Concerned About Beyaz Side Effects? You Should Be
Washington, DC: It’s amazing the things you find on product labeling and product websites. It’s all there. And anyone who has any query or question over potential Beyaz side effects need only read the information that’s readily available from the manufacturer. In so doing, the manufacturer is telling you that there is the potential risk for serious health consequences, while taking your money and continuing to sell the product [READ MORE]
Birth Control Lawsuits Filed Overseas
Miami, FL: If it seems as though birth control issues such as Beyaz side effects and other birth control side effects have been in the news for a while, they have. Litigation involving birth control similar to Beyaz birth control has been going for a few years. Although Beyaz lawsuits are not in the news as much as other, similar birth control such as Yasmin or Yaz, lawsuits are reportedly being filed against the makers of a variety of combined oral contraceptives, alleging patients were not adequately warned about the risks [READ MORE]
Beyaz and Other Birth Control Side Effects
Washington, DC: Almost exactly two years ago, an advisory panel for the US Food and Drug Administration (FDA) voted to keep Beyaz birth control and other, similar birth control on the market with stronger warnings. The advisory panel met because of concerns about Beyaz side effects - side effects that were linked to birth control that contained drospirenone. Despite concerns about health risks to young women, the side effects of Beyaz were reportedly not serious enough to remove the birth control from the market [READ MORE]
MORE BEYAZ LEGAL NEWS
YOUR BEYAZ STORIES
Publish your Beyaz experience here for our readers to learn from.
READ MORE [ Drugs/Medical Settlements and Legal News ]